Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
Activity Details
350
Tue, 7/31/2018,
10:30 AM -
12:20 PM
CC-West 304/305
Statistical Issues In Drug Development - 1 — Contributed Papers
Biopharmaceutical Section
Chair(s): Tian Dai
10:35 AM
Reversals in Early Phase Dose Finding Trials
Bethany Horton, University of Virginia ; John O'Quigley, Universit'e Pierre et Marie Curie, ; Mark Conaway, University of Virginia
10:50 AM
The Emerging and Merging Fields of Benefit-Risk and Health Technology Assessments
Susan Talbot, Amgen Ltd ; Shahrul Mt-Isa, Merck; Jixian Wang, Celgene
11:05 AM
Application of Bayesian Approach in Evaluating Rare Adverse Events During a Clinical Study
Ying Grace Li, Eli Lilly and Company
11:20 AM
Assessment of Treatment Effects in Single Cases and Small Groups: Assumptions, Logic, Algorithm, Computations
Lev Sverdlov
11:35 AM
Monitoring Vaccine Safety by Studying Temporal Trend of Adverse Events Using VAERS
Jing Huang, University of Pennsylvania ; Yi Cai, Pieces Technology; Jingcheng Du, University of Texas Health Science Center; Ruosha Li, University of Texas School of Public Health; Susan S Ellenberg, University of Pennsylvania; Sean Hennessy, University of Pennsylvania; Cui Tao, University of Texas Health Science Center; Yong Chen, University of Pennsylvania
11:50 AM
Network Meta-Analysis: On the Use of the Standard Contrast-Based Approach in Disconnected Networks
Audrey Béliveau, University of Waterloo ; Paul Gustafson, University of British Columbia
12:05 PM
Three Intervals Used in Setting Quality Specification Limits
Yi Tsong, CDER, FDA ; Xin Hu, George Washington University
